{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T19:28:25Z","timestamp":1769455705208,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.vaccine.2022.12.007","type":"journal-article","created":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T11:25:27Z","timestamp":1675941927000},"page":"1753-1759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A Phase II\/III, Multicenter, Observer-blinded, Randomized, Non-inferiority and Safety, study of typhoid conjugate vaccine (EuTCV) compared to Typbar-TCV\u00ae in healthy 6 Months-45 years aged participants"],"prefix":"10.1016","volume":"41","author":[{"given":"Yeong","family":"Ok Baik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youngjin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chankyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo","family":"Kyung Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jooyoung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meixiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DaYe","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Young Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae","family":"Jun Yong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong","family":"Woo Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sungho","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suwon","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung","family":"Hyun Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seuk","family":"Keun Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2022.12.007_b0005","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1093\/cid\/ciy1094","article-title":"Global typhoid fever incidence: a systematic review and meta-analysis","volume":"68","author":"Marchello","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2022.12.007_b0010","unstructured":"CDC. Typhoid Fever and Paratyphoid Fever. 2021 March 30, 2021 [cited 2021 March 10, 2022]."},{"issue":"22","key":"10.1016\/j.vaccine.2022.12.007_b0015","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMra020201","article-title":"Typhoid fever","volume":"347","author":"Parry","year":"2002","journal-title":"N Engl J Med"},{"issue":"6002","key":"10.1016\/j.vaccine.2022.12.007_b0020","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1126\/science.1194598","article-title":"Salmonella pathogenesis and processing of secreted effectors by caspase-3","volume":"330","author":"Srikanth","year":"2010","journal-title":"Science"},{"issue":"Suppl 6","key":"10.1016\/j.vaccine.2022.12.007_b0025","doi-asserted-by":"crossref","first-page":"S499","DOI":"10.1093\/cid\/ciz705","article-title":"Spatial and temporal patterns of typhoid and paratyphoid fever outbreaks: a worldwide review, 1990\u20132018","volume":"69","author":"Kim","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2022.12.007_b0030","doi-asserted-by":"crossref","unstructured":"WHO. Typhoid vaccines. 2017 January 13, 2017 [cited 2022 March 10, 2022].","DOI":"10.1080\/21645515.2017.1333681"},{"issue":"18","key":"10.1016\/j.vaccine.2022.12.007_b0035","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1016\/j.vaccine.2005.07.111","article-title":"Vaccines against typhoid fever","volume":"24","author":"Guzman","year":"2006","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2022.12.007_b0040","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1080\/21645515.2015.1086048","article-title":"Potential protective immunogenicity of tetanus toxoid, diphtheria toxoid and Cross Reacting Material 197 (CRM197) when used as carrier proteins in glycoconjugates","volume":"12","author":"Broker","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"10.1016\/j.vaccine.2022.12.007_b0045","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180238","article-title":"Structural and immunological characterization of E. coli derived recombinant CRM197 protein used as carrier in conjugate vaccines","volume":"38","author":"Mishra","year":"2018","journal-title":"Biosci Rep"},{"key":"10.1016\/j.vaccine.2022.12.007_b0050","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1745-6215-12-106","article-title":"Through the looking glass: understanding non-inferiority","volume":"12","author":"Schumi","year":"2011","journal-title":"Trials"},{"issue":"19","key":"10.1016\/j.vaccine.2022.12.007_b0055","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1016\/j.vaccine.2021.03.089","article-title":"An open-label, comparative, single dose, clinical Phase study to assess the safety and immunogenicity of typhoid conjugate vaccine (Vi-CRM197) in healthy Filipino adults","volume":"39","author":"Choi","year":"2021","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2022.12.007_b0060","doi-asserted-by":"crossref","first-page":"e0008040","DOI":"10.1371\/journal.pntd.0008040","article-title":"Surveillance of Salmonella enterica serovar Typhi in Colombia, 2012\u20132015","volume":"14","author":"Diaz-Guevara","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2022.12.007_b0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s41182-017-0043-z","article-title":"Prevalence and characterization of Salmonella among humans in Ghana","volume":"45","author":"Andoh","year":"2017","journal-title":"Trop Med Health"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2022.12.007_b0070","doi-asserted-by":"crossref","first-page":"S276","DOI":"10.1093\/cid\/ciaa1323","article-title":"Antimicrobial resistance in typhoidal salmonella: surveillance for enteric fever in asia project, 2016\u20132019","volume":"71","author":"Qamar","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2022.12.007_b0075","doi-asserted-by":"crossref","unstructured":"R, Milligan, et al., Vaccines for preventing typhoid fever. Cochrane Database Syst Rev, 2018. 5: p. CD001261.","DOI":"10.1002\/14651858.CD001261.pub4"},{"issue":"9","key":"10.1016\/j.vaccine.2022.12.007_b0080","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00006454-199909000-00004","article-title":"Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers","volume":"18","author":"Shinefield","year":"1999","journal-title":"Pediatr Infect Dis J"},{"issue":"35","key":"10.1016\/j.vaccine.2022.12.007_b0085","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1016\/j.vaccine.2008.05.087","article-title":"A clinical trial examining the effect of increased total CRM(197) carrier protein dose on the antibody response to Haemophilus influenzae type b CRM(197) conjugate vaccine","volume":"26","author":"Usonis","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.12.007_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.745699","article-title":"A novel combined conjugate therapeutic cancer vaccine, recombinant EGF-CRM197, in Patients With advanced solid tumors: a phase I clinical study","volume":"11","author":"Xiong","year":"2021","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.vaccine.2022.12.007_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9040771","article-title":"Vaccines to prevent meningitis: historical perspectives and future directions","volume":"9","author":"Alderson","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.vaccine.2022.12.007_b0100","first-page":"1","article-title":"Why paracetamol (acetaminophen) is a suitable first choice for treating mild to moderate acute pain in adults with liver, kidney or cardiovascular disease, gastrointestinal disorders, asthma, or who are older","author":"Alchin","year":"2022","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.vaccine.2022.12.007_b0105","first-page":"1","article-title":"A multicenter, single-blind, randomized, phase-2\/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E\u2019s Vi-capsular polysaccharide-CRM<sub>197<\/sub> conjugate typhoid vaccine (TyphiBEV<sup>TM<\/sup>) in healthy infan","author":"Thuluva","year":"2022","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"10.1016\/j.vaccine.2022.12.007_b0110","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1128\/iai.61.3.1149-1151.1993","article-title":"Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children","volume":"61","author":"Cryz","year":"1993","journal-title":"Infect Immun"},{"issue":"23","key":"10.1016\/j.vaccine.2022.12.007_b0115","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1905047","article-title":"Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in nepal","volume":"381","author":"Shakya","year":"2019","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.vaccine.2022.12.007_b0120","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa2035916","article-title":"Safety and efficacy of a typhoid conjugate vaccine in malawian children","volume":"385","author":"Patel","year":"2021","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.vaccine.2022.12.007_b0125","doi-asserted-by":"crossref","first-page":"e1154","DOI":"10.1016\/S2214-109X(21)00255-2","article-title":"Effectiveness of typhoid conjugate vaccine against culture-confirmed Salmonella enterica serotype Typhi in an extensively drug-resistant outbreak setting of Hyderabad, Pakistan: a cohort study","volume":"9","author":"Yousafzai","year":"2021","journal-title":"Lancet Glob Health"},{"issue":"10111","key":"10.1016\/j.vaccine.2022.12.007_b0130","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial","volume":"390","author":"Jin","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2022.12.007_b0135","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.vaccine.2010.11.022","article-title":"Vi-CRM197 as a new conjugate vaccine against Salmonella Typhi","volume":"29","author":"Micoli","year":"2011","journal-title":"Vaccine"},{"issue":"6375","key":"10.1016\/j.vaccine.2022.12.007_b0140","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/357216a0","article-title":"The crystal structure of diphtheria toxin","volume":"357","author":"Choe","year":"1992","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.vaccine.2022.12.007_b0145","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1016\/j.vaccine.2021.03.070","article-title":"Non-clinical immunological comparison of a Next-Generation 24-valent pneumococcal conjugate vaccine (VAX-24) using site-specific carrier protein conjugation to the current standard of care (PCV13 and PPV23)","volume":"39","author":"Fairman","year":"2021","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2022.12.007_b0150","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1086\/529142","article-title":"Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory","volume":"46","author":"de Roux","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"35","key":"10.1016\/j.vaccine.2022.12.007_b0155","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1016\/j.vaccine.2013.04.085","article-title":"Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults","volume":"31","author":"Jackson","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2022.12.007_b0160","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1128\/iai.65.1.242-247.1997","article-title":"Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults","volume":"65","author":"Shelly","year":"1997","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2022.12.007_b0165","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1473-3099(13)70241-X","article-title":"Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials","volume":"14","author":"Bhutta","year":"2014","journal-title":"Lancet Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22015249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22015249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:23:02Z","timestamp":1759404182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22015249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0264410X22015249"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.12.007","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Phase II\/III, Multicenter, Observer-blinded, Randomized, Non-inferiority and Safety, study of typhoid conjugate vaccine (EuTCV) compared to Typbar-TCV\u00ae in healthy 6 Months-45 years aged participants","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}